Hormones & HRT - Testosterone
Low testosterone: symptoms, diagnosis and treatment
Last updated 30 September 2026. How we write this .
Low testosterone is diagnosed from compatible symptoms and repeatedly low blood levels. Testosterone replacement can help confirmed deficiency, but benefits, fertility and safety need careful assessment.
Start here Low testosterone is diagnosed from compatible symptoms and repeatedly low blood levels. Testosterone replacement can help confirmed deficiency, but benefits, fertility and safety need careful assessment.
By the end, you will understand What low testosterone means How the hormone system works Which symptoms are informative? Key words used in this lesson Placebo An inactive comparison given so that the effect of expectation can be separated from the effect of the intervention itself. Without one, improvement over time cannot be attributed to the treatment. Prescription-only medicine A licensed medicine that may lawfully be supplied only against a prescription following clinical assessment. The lawful route to one is a qualified prescriber and a registered pharmacy. Full plain-English glossary
Where this information comes from Claim-cited evidence. Central research claims on this lesson are linked to specific studies or official guidance.
This lesson links the specific studies and guidance used for its central claims.
Our standard: expert or athlete opinion may illustrate a viewpoint, but it is never treated as proof. Read the editorial policy .
Report an error or outdated claim .
Low testosterone can affect sexual desire, spontaneous erections, muscle and bone, but fatigue or low mood alone does not establish a hormone deficiency. Diagnosis combines compatible symptoms with repeatedly low blood results and an assessment of the cause. Testosterone replacement can help some people with confirmed deficiency, but its benefits vary, it can suppress sperm production, and it requires monitoring.
What low testosterone means
Testosterone is a hormone that influences sexual development, reproductive function, red blood cell production, muscle and bone. In adult men, most comes from the testes. Some testosterone is converted into oestradiol, which also contributes to bone health and the hormonal feedback system.
Hypogonadism means reduced function of the testes or the signals controlling them. A low laboratory result is a finding, not a complete diagnosis. Its significance depends on symptoms, whether it persists, and whether it reflects an underlying disorder or a temporary response to circumstances.
This lesson mainly concerns adult men being assessed for testosterone deficiency. Adult diagnostic criteria do not apply directly to children or adolescents. Testosterone assessment in women and hormone care for transgender people involve different clinical questions and cannot simply borrow male reference ranges.
How the hormone system works
The hypothalamus in the brain signals the pituitary gland, which releases luteinising hormone and follicle-stimulating hormone. Luteinising hormone stimulates testosterone production in the testes. Follicle-stimulating hormone works alongside the high testosterone concentration inside the testes to support sperm production.
Testosterone and oestradiol feed information back to the brain and pituitary. When their levels rise, the upstream signals usually fall. This feedback explains why adding testosterone from outside the body can reduce sperm production even while testosterone measured in the bloodstream rises.
In primary hypogonadism, the testes cannot respond adequately, so luteinising hormone often rises as the pituitary attempts to compensate. In secondary hypogonadism, signals from the hypothalamus or pituitary are insufficient. These patterns matter because similar testosterone results can have different causes and implications.
Not every reduction represents permanent damage. Acute illness, insufficient energy intake, obesity, disrupted sleep and some medicines can influence this system. Obesity can also lower a testosterone-binding protein, changing the total blood result without an equivalent fall in the unbound hormone.
Which symptoms are informative?
Reduced sexual desire and fewer spontaneous erections are more suggestive of testosterone deficiency than tiredness alone, particularly when they occur together. Persistent deficiency can also contribute to reduced body hair, loss of muscle, reduced bone density or anaemia. None of these findings independently proves the diagnosis.
Fatigue, poor concentration and low mood overlap with many other conditions and life circumstances. Sleep apnoea, depression, thyroid problems, illness, medication effects and prolonged energy deficit can produce similar experiences. A symptom checklist cannot reliably separate these possibilities.
Erectile difficulties are not a direct testosterone meter. Blood vessel health, nerve function, psychological factors and medicines also influence erections. Likewise, infertility and testosterone deficiency overlap but are not interchangeable: a blood testosterone result does not measure sperm production.
The NHS describes the phrase 'male menopause' as misleading. Men do not generally experience the abrupt hormonal transition associated with menopause. Age-related changes are variable, and symptoms developing in midlife should not automatically be attributed to testosterone.
Why diagnosis needs more than one test
Testosterone varies across the day and between days. Sleep, meals and acute illness can affect measurements. Clinical assessment therefore generally uses repeat morning blood samples under appropriate conditions, rather than accepting a single low result as definitive. Shift work can complicate interpretation because waking and sleeping patterns differ.
Most initial tests measure total testosterone, including hormone attached to proteins. Sex hormone-binding globulin, or SHBG, carries a substantial proportion. When SHBG is unusually low or high, total testosterone can give an incomplete picture of hormone availability.
Clinicians may use SHBG and other measurements to calculate free testosterone when results are borderline or binding proteins are likely to be altered. This calculation is an estimate, and laboratory methods differ. A value should be interpreted against the relevant method and clinical context, not an internet target labelled 'optimal'.
Further assessment may include pituitary hormones, prolactin and investigations guided by the history. The purpose is to understand why testosterone is low, including whether testicular disease, pituitary disease, medicines or broader health factors are involved. Specialist assessment or imaging is relevant in selected cases, not automatically after every borderline result. On the NHS, a GP can arrange blood tests. If they suggest a deficiency, the usual route is referral to an endocrinologist, a hormone specialist, who confirms the diagnosis before any treatment is considered.
A reference interval describes laboratory results in a comparison population. It does not identify a personal performance target, and a borderline result cannot explain every symptom by itself.
What the evidence shows about replacement
Testosterone replacement has an established clinical role in confirmed deficiency caused by disorders of the testes or their hormonal control. Its purpose is to restore deficient hormone activity and assess meaningful health outcomes. This is different from assuming that increasing testosterone within or above a normal range improves general wellbeing.
Randomised, placebo-controlled studies provide stronger evidence of benefit than testimonials because they help separate hormone effects from expectation and natural fluctuation. The Testosterone Trials in older men with low levels found improvements in sexual function and some improvement in mood. They did not show a clear benefit on the main fatigue outcome.
Changes in body composition do not necessarily translate into better everyday function. More lean tissue is not the same outcome as greater strength, fewer falls or improved independence. Similarly, an improvement in a blood result does not establish that the symptom prompting assessment has improved.
Bone findings illustrate this distinction. Testosterone can improve bone density in some groups, but the fracture substudy of the large TRAVERSE trial did not demonstrate fracture prevention and recorded more clinical fractures in the testosterone group. A favourable intermediate measurement cannot substitute for evidence about the outcome people actually care about.
Observational studies associate low testosterone with poorer health and earlier death, but illness and obesity can themselves lower testosterone. These associations do not establish that replacement extends life. Evidence for testosterone as a general longevity intervention remains insufficient.
Trade-offs, fertility and monitoring
The suppression of sperm production is a major trade-off, especially for anyone considering future biological parenthood. Recovery after testosterone exposure varies and cannot be assumed to be immediate or complete. Fertility goals therefore change the clinical discussion; a higher blood testosterone result does not mean improved fertility.
Testosterone can increase red blood cell production, sometimes raising haematocrit, the proportion of blood occupied by those cells, excessively. Other concerns include acne, fluid retention and changes in blood pressure. Monitoring considers symptoms and adverse effects alongside blood measurements, with prostate assessment where appropriate.
TRAVERSE studied men with confirmed low testosterone and existing cardiovascular disease or increased cardiovascular risk. It did not find a higher rate of its main combined cardiovascular outcome with testosterone than placebo during follow-up. However, some other adverse events were more frequent, and the findings do not establish lifelong safety or apply automatically to every population.
People with certain prostate or breast cancers, elevated haematocrit, severe sleep apnoea that is not being managed, or significant unstable illness require particular clinical consideration. Decisions depend on the underlying condition and overall history. Prescribed replacement is not interchangeable with non-medical performance-enhancing use, which involves different exposures and risks.
In the UK, testosterone is a prescription-only medicine. Anabolic steroids, including testosterone, are Class C drugs under the Misuse of Drugs Act, and the NHS says they can only be issued by a pharmacist with a prescription. Supplying them to others, even friends, is illegal. Products bought outside a prescription are unregulated, and the NHS links anabolic steroid misuse to heart attack, stroke, liver and kidney problems, and infections from shared needles.
How to judge claims and keep perspective
A credible explanation connects the diagnosis, the study population and the outcome. Evidence from men with clear hormone deficiency cannot automatically justify use in healthy people with normal levels. Mechanistic or animal findings can explain a possibility, but cannot establish that a person will feel better or live longer.
Was deficiency established from symptoms and repeat laboratory measurements, or only a questionnaire or single result? Was the evidence randomised and controlled, observational, or limited to laboratory and animal work? Did the study measure meaningful outcomes, such as sexual function, rather than only hormone levels or body composition? Were fertility effects, adverse events and the limits of follow-up reported? Does the claim acknowledge other explanations for fatigue, low mood or erectile difficulties? Anyone already receiving hormone care should discuss symptoms and results with their care team. Consumer devices and wellness scores cannot diagnose testosterone deficiency, and medicines should not be changed based on them. The useful clinical question is whether the whole pattern supports deficiency and whether the proposed approach addresses its cause and consequences.
Stop exertion if sudden chest pain or severe breathlessness occurs. Call 999 for chest pain that persists, spreads, or occurs with sweating or breathlessness, or for severe difficulty breathing. Persistent fatigue, low mood or sexual changes warrant contact with a GP; NHS 111 is the route for urgent concerns when the appropriate service is unclear. Anyone using testosterone or anabolic steroids without a prescription who has chest pain, a painful swollen leg, or sudden weakness or speech problems should call 999.
This lesson is general education, not medical advice, and is not a recommendation to start, stop or change any hormone treatment. Your GP, practice nurse or a specialist can discuss what fits your history.
Related in this classroom Related in other classrooms The studies behind this page Testosterone therapy for hypogonadism guideline resources - Endocrine Society clinical practice guidelineStatement on testosterone replacement therapy - Endocrine Society, 2026Sources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.